KIG
ABBV icon

Kowal Investment Group’s AbbVie ABBV Stock Holding History

Kowal Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.2M Buy
16,186
+1,180
+8% +$220K 0.59% 25
2024
Q2 		$2.57M Buy
15,006
+671
+5% +$111K 0.51% 29
2024
Q1 		$2.61M Buy
14,335
+1,671
+13% +$288K 0.56% 23
2023
Q4 		$1.96M Buy
12,664
+949
+8% +$138K 0.46% 32
2023
Q3 		$1.75M Sell
11,715
-502
-4% -$73.7K 0.47% 27
2023
Q2 		$1.65M Buy
12,217
+352
+3% +$51.6K 0.44% 29
2023
Q1 		$1.89M Buy
11,865
+248
+2% +$37.9K 0.54% 26
2022
Q4 		$1.88M Buy
11,617
+171
+1% +$26.2K 0.56% 26
2022
Q3 		$1.54M Buy
11,446
+252
+2% +$36.2K 0.52% 24
2022
Q2 		$1.72M Sell
11,194
-122
-1% -$18.6K 0.56% 19
2022
Q1 		$1.83M Buy
11,316
+7,360
+186% +$1.07M 0.56% 15
2021
Q4 		$536K Buy
3,956
+229
+6% +$27.1K 0.16% 51
2021
Q3 		$402K Sell
3,727
-705
-16% -$80.6K 0.13% 62
2021
Q2 		$499K Buy
4,432
+43
+1% +$4.84K 0.18% 49
2021
Q1 		$475K Buy
4,389
+147
+3% +$15.7K 0.19% 47
2020
Q4 		$466K Buy
+4,242
New +$408K 0.22% 48

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Kowal Investment Group's ABBV Position: Q3 2024 in Review

Kowal Investment Group increased its AbbVie (ABBV) stake by 7.9% in Q3 2024, buying an estimated $220K and bringing the position to 16,186 shares worth $3.2M. The position accounts for 0.59% of the portfolio, ranked #25.

Kowal Investment Group first reported a position in ABBV in Q4 2020 and has held it in 16 quarters since. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • Kowal Investment Group held 16,186 shares of AbbVie worth $3.2M as of Q3 2024.
  • Kowal Investment Group bought 1,180 AbbVie shares in Q3 2024, an estimated $220K.
  • AbbVie made up 0.59% of Kowal Investment Group's portfolio in Q3 2024, its #25 holding.
  • Kowal Investment Group first reported a position in AbbVie in Q4 2020 and has held it in 16 quarters since.
  • 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Kowal Investment Group's 13F filing for Q3 2024, filed 16 Oct 2024.